Iris E. Eder - Concepedia

Author

Iris E. Eder

Universität Innsbruck ORCID

Also Known As

Christopher Haqq, Eder, Iris, Helmut Klocker, I E Eder, I Eder, I. E. Eder, I. Eder, I.E. Eder, IE Eder, IRIS EDER

138

Publications

3.7K

Citations

H-Index

Concepts

All Affiliations

Universität Innsbruck Innsbruck Medical University German Cancer Research Center Oroboros Instruments (Austria)University of Florence

About

Iris E. Eder is an author at Universität Innsbruck specializing in medicine, cell biology, and urology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	19	1.5K
2	Engineering	3	3	149
3	Health Sciences	3	3	128
4	Biochemistry	2	2	57
5	Natural Sciences	1	1	25

Iris E. Eder

Publications

Citations

H-Index

Page 1

	Year	Citations
Interleukin-6 regulates prostate-specific protein expression in prostate carcinoma cells by activation of the androgen receptor. Alfred Hobisch, Iris E. Eder, Thomas Pütz, PubMed Androgen ReceptorTranscriptional RegulationUrologyProstate-specific Protein ExpressionCytokine	1998	439
Switch from antagonist to agonist of the androgen receptor blocker bicalutamide is associated with prostate tumour progression in a new model system Zoran Čulig, Jens Hoffmann, Martin Erdel, British Journal of Cancer	1999	419
The Glucocorticoid Receptor Is a Key Player for Prostate Cancer Cell Survival and a Target for Improved Antiandrogen Therapy Martin Puhr, Julia Hoefer, Andrea Eigentler, Clinical Cancer Research	2017	166
Epidermal growth factor (EGF) receptor blockade inhibits the action of EGF, insulin-like growth factor I, and a protein kinase A activator on the mitogen-activated protein kinase pathway in prostate cancer cell lines. Thomas Pütz, Zoran Čulig, Iris E. Eder, PubMed UrologySignal TransductionEpidermal Growth FactorInsulin-like Growth FactorCell Regulation	1999	159
Inhibition of LNCaP prostate cancer cells by means of androgen receptor antisense oligonucleotides Iris E. Eder, Zoran Čulig, Reinhold Ramoner, Cancer Gene Therapy MedicineHormonal ReceptorOligonucleotideAntisense TherapyProstatic Disease	2000	156
AGE DEPENDENT APOPTOSIS AND LOSS OF RHABDOSPHINCTER CELLS Hannes Strasser, Martin Tiefenthaler, Martin Steinlechner, The Journal of Urology	2000	143
Androgen receptor down regulation by small interference RNA induces cell growth inhibition in androgen sensitive as well as in androgen independent prostate cancer cells Petra Hååg, Jasmin Bektić, Georg Bartsch, The Journal of Steroid Biochemistry and Molecular Biology Developmental BiologyHormonal ReceptorGrowth InhibitionAndrogen SensitiveSmall Rna	2005	139
Inhibition of LNCaP prostate tumor growth in vivo by an antisense oligonucleotide directed against the human androgen receptor Iris E. Eder, Jens Hoffmann, Hermann Rogatsch, Cancer Gene Therapy MedicineHormonal ReceptorOligonucleotideAntisense OligonucleotideAntisense Therapy	2002	106
Cancer-associated fibroblasts promote prostate tumor growth and progression through upregulation of cholesterol and steroid biosynthesis Hannes Neuwirt, Jan Bouchal, Gvantsa Kharaishvili, Cell Communication and Signaling	2020	101
Long‐term androgen‐ablation causes increased resistance to PI3K/Akt pathway inhibition in prostate cancer cells Karina Pfeil, Iris E. Eder, Thomas Pütz, The Prostate	2003	96

Page 1